SLC12A2 and cancer: In order to further optimize the prediction model and improve the clinical transformation efficiency, we performed a stepwise analysis of the impact of KCC2 (Figures 2A, B) and NKCC1 (Figures 3A, B) in pan-cancer progression-free survival (PFS) and overall survival (OS).